trending Market Intelligence /marketintelligence/en/news-insights/trending/-mzzkATJIwCBwia99-fd9g2 content esgSubNav
In This List

Biostage appoints board member

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Biostage appoints board member

Holliston, Mass.-based biotechnology company Biostage Inc. elected Wei Zhang to its board.

Zhang is a professor of innovation at Peking University in Beijing. At Peking University, Zhang headed business strategy programs for clients such as Johnson & Johnson and Novartis AG, among others, Biostage said in a statement.

Zhang is expected to help the company expand its programs in China.

Biostage is developing bioengineered organ implants to treat life-threatening conditions.